Semax

Semax is a synthetic peptide based on an ACTH fragment and studied in neuroprotection, cognition, ischemia models, neurotrophic signaling, and stress response.

Reported experimental effects include modulation of BDNF and related neurotrophic pathways, monoamine signaling, oxidative stress, and inflammatory gene expression.

Limited human evidence with substantial regional and preclinical literature.

Level III, Limited human evidence

Study quality, independent replication, formulation standardization, and relevance to modern clinical practice vary considerably.

Long-term CNS, endocrine, immunogenicity, reproductive, and interaction risks are not well characterized.

No FDA-approved drug product; FDA has identified safety-information gaps for compounded Semax.

Supplied strictly for in-vitro and ex-vivo laboratory research. Not for human or veterinary administration, diagnostic, or therapeutic use. Import and regulatory compliance remain the responsibility of the receiving researcher.

• Semax, 10 mgLyophilized

Every Cendrix lot ships with an HPLC purity chromatogram, mass-spectrometry identity confirmation, appearance and reconstitution observations, and endotoxin testing where applicable. Lot certificates are retrievable from the Quality page using the lot number printed on the vial.

External searches link to PubMed, ClinicalTrials.gov, Google Scholar, and FDA records. Cendrix does not endorse interpretations published in third-party sources.